Showing results (571-580 of 5,043) with videos related to
Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|June 14, 2021
An impact of air pollution on moderate to severe relapses among multiple sclerosis patientsMiri Elgabsi, Lena Novack, Shaked Yarza, et al.Multiple Sclerosis and Related Disorders|June 13, 2021
Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple SclerosisYunier Broche-Pérez, Rodneys M Jiménez-Morales, Laura Ortiz Monasterio-Ramos, et al.Multiple Sclerosis and Related Disorders|June 12, 2021
Cross-sectional analysis of peripheral blood mononuclear cells in lymphopenic and non-lymphopenic relapsing-remitting multiple sclerosis patients treated with dimethyl fumarateChieh-Hsin Lee, Bei Jiang, Maryam Nakhaei-Nejad, et al.Multiple Sclerosis and Related Disorders|June 12, 2021
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysisXindi Li, Chengyi Zhang, Dongmei Jia, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)B O Khatri, J Pelletier, L Kappos, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Co-existence of neurofibromatosis type 2 and multiple sclerosis: A case reportHoda Naghshineh, Daryoush Shahin, Mohammad Ali Sahraian, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
A case of anti-N-methyl-d-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesionsAkitoshi Takeda, Hiroyuki Shimada, Akiko Tamura, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimodPaul Schurmann, Sukhdeep Basra, Omar G Awar, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosisDavid Baker, Gareth Pryce, Samuel J Jackson, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorderChiara Costanzi, Dennis Bourdette, Joseph E Parisi, et al.Pageof 505